Sector News

Stryker to build new innovation centre in Cork

September 23, 2014
Life sciences
US medical technologies company Stryker is to build a new 44,000 square foot surgical innovation centre in Cork, which will combine all Ireland-based research and new product development activities and support functions within one purpose-built facility. Construction is set to commence in the last months of this year, with completion expected in Q4 2015.
 
“This state-of-the-art facility will drive innovation by giving us the ability to design, develop and test new products in conditions that mimic real life,” Stryker Instruments President Jim Heath said.
 
The innovation centre, which Stryker says will fuel future growth, will focus on the research and development of products, technologies and solutions to reduce surgical procedure time and healthcare costs while improving surgical precision and clinical outcomes in the areas of bone cutting, soft tissue dissection and adjacent areas across a broad spectrum of surgical specialities and procedures. It is being constructed with the support of the IDA.
 
Stryker says the facility will feature state-of-the-art R&D facilities for product design and process development and a customer experience laboratory that will allow engineers and surgeons to test and evaluate new ideas, technology and product designs in a simulated operating room and surgical environment.
Stryker first came to Ireland in 1998 and now employs over 2,200 people at four sites between Cork and Limerick, including over 150 people in research and development.
 
Source: Irish Times

comments closed

Related News

February 4, 2023

MedTrace receives U.S. patent for diagnosing the human heart

Life sciences

The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the human heart via 15O-water PET. The patented method is the foundation of the company’s software aQuant, currently under development. Hendrik “Hans” Harms, PhD and Senior Scientist at MedTrace, and Jens Soerensen, Professor and Clinical Advisor to MedTrace, are the originators of the method.

February 4, 2023

Roche taps insider Teresa Graham for top pharma job as setbacks prompt M&A questions

Life sciences

Teresa Graham, currently head of global product strategy for Roche pharma, will become the division’s new CEO next month, Roche said Thursday. Simultaneously, Roche is elevating Levi Garraway, chief medical officer, to the executive committee.

February 4, 2023

J&J’s pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries

Life sciences

Fierce Pharma has obtained internal documents and video of a town hall meeting conducted this week describing what J&J called a “comprehensive review” of its portfolio. Moving forward, J&J plans to operate its vaccines and infectious diseases outfits as one group, the executives explained.

How can we help you?

We're easy to reach